220 Participants Needed

Family-Focused Therapy for Psychosis

Recruiting at 6 trial locations
DM
DJ
DM
Overseen ByDaniel Mathalon, MD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Los Angeles
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I have to stop taking my current medications for the trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, you must be willing to taper individual therapy to monthly sessions by the start of treatment.

Do I need to stop taking my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. However, it does mention that participants must be willing to reduce individual therapy sessions to once a month by the start of treatment.

What data supports the idea that Family-Focused Therapy for Psychosis is an effective treatment?

The available research shows that Family-Focused Therapy (FFT) is effective for individuals at high risk for psychosis. One study found that FFT led to greater improvements in family communication compared to a shorter family education program. Another study showed that FFT was more effective than brief psychoeducation in reducing the severity of early psychotic symptoms over six months. Additionally, FFT has been associated with reduced mood episodes in youth at high risk for bipolar disorder, suggesting its effectiveness in improving mood and social functioning.12345

What data supports the effectiveness of the treatment Family-Focused Therapy for Psychosis?

Research shows that Family-Focused Therapy (FFT) can help improve communication and reduce symptoms in young people at high risk for psychosis. It has also been effective in reducing mood episodes in youth at high risk for bipolar disorder, suggesting its potential benefits for similar conditions.12345

What safety data exists for Family-Focused Therapy for Psychosis?

The studies reviewed do not explicitly mention safety data for Family-Focused Therapy (FFT) for psychosis. However, they suggest that FFT is effective in reducing symptoms and improving family functioning in individuals at high risk for psychosis and bipolar disorder. The therapy involves psychoeducation, communication training, and problem-solving skills, and has been compared to enhanced care (EC) and psychoeducational interventions. No adverse safety concerns are reported in these studies, indicating that FFT is generally considered safe for participants.12356

Is Family-Focused Therapy (FFT) safe for humans?

Family-Focused Therapy (FFT) has been studied in various forms and for different conditions, such as psychosis and bipolar disorder, and no safety concerns have been reported in these studies. It involves psychoeducation, communication training, and problem-solving skills, which are generally considered safe for participants.12356

Is Family Focused Therapy a promising treatment for young people at high risk of psychosis?

Yes, Family Focused Therapy (FFT) is a promising treatment for young people at high risk of psychosis. Research shows that FFT helps reduce the severity of early psychotic symptoms and improves family communication. It is more effective than basic education alone and can be implemented efficiently with community clinicians.23457

How is Family Focused Therapy for Clinical High Risk Youth (FFT-CHR) different from other treatments for psychosis?

Family Focused Therapy for Clinical High Risk Youth (FFT-CHR) is unique because it combines psychoeducation, communication training, and problem-solving skills in an 18-session format, which has been shown to improve family communication and reduce symptoms more effectively than brief psychoeducation alone for those at high risk of psychosis.23457

What is the purpose of this trial?

The present study is a confirmatory efficacy trial of Family Focused Therapy for youth at clinical high risk for psychosis (FFT-CHR). This trial is sponsored by seven mature CHR clinical research programs from the North American Prodrome Longitudinal Study (NAPLS). The young clinical high risk sample (N = 220 youth ages 13-25) is to be followed at 6-month intervals for 18 months.

Research Team

DJ

David J Miklowitz, Ph.D.

Principal Investigator

University of California, Los Angeles

KS

Kristin Cadenhead, MD

Principal Investigator

University of California, San Diego

SW

Scott Woods, MD

Principal Investigator

Yale University

JM

Jean Addington, Ph.D.

Principal Investigator

University of Calgary

AM

Andrea M. Auther, Ph.D.

Principal Investigator

Zucker Hillside Hospital at Hofstra / Northwell Health

BA

Barbara A. Cornblatt, Ph.D., M.B.A.

Principal Investigator

Hofstra University / Northwell Health

DH

Daniel Mathalon, MD

Principal Investigator

University of California, San Francisco

HK

Holly K. Hamilton, Ph.D.

Principal Investigator

University of California, San Francisco

CE

Carrie E. Bearden, Ph.D.

Principal Investigator

University of California, Los Angeles

MF

Michelle Friedman-Yakoobian, Ph.D.

Principal Investigator

Harvard Medical School/Massachusetts Mental Health Center

Eligibility Criteria

This trial is for English-speaking youth aged 13-25 at high risk for psychosis, who have a parent or guardian involved in their life and can consent to treatment. Participants must show early signs of psychosis but cannot have a full psychotic disorder, severe substance abuse issues, or intellectual impairment.

Inclusion Criteria

I am at high risk for psychosis, showing early symptoms not explained by another mental health condition.
Participants must be able to understand and sign an informed consent (or assent for minors) document in English
I have a parent or guardian who can join the study with me, speaks English, and we meet at least 4 hours a week.

Exclusion Criteria

Current or lifetime Axis 1 psychotic disorder by DSM-5 criteria
My IQ is below 70.
Unwilling or unable to taper individual therapy to monthly by start of treatment
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Family Focused Therapy (FFT-CHR) or Enhanced Care (EC) for 6 months, including family and individual sessions

6 months
18 family sessions (FFT-CHR) or 3 family sessions and 5 individual sessions (EC)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 6-month intervals

12 months
Assessments at 6, 12, and 18 months

Treatment Details

Interventions

  • Enhanced Care (EC)
  • Family Focused Therapy for Clinical High Risk Youth (FFT-CHR)
Trial Overview The study tests Family Focused Therapy (FFT-CHR) against Enhanced Care (EC) in young individuals showing early symptoms of psychosis. The participants will be monitored every six months over an 18-month period by established clinical research programs.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: FFT-CHRExperimental Treatment1 Intervention
Family-Focused Therapy for Clinical High-Risk Individuals
Group II: Enhanced CareActive Control1 Intervention
Enhanced Care Psychoeducation for Clinical High-Risk Individuals

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Los Angeles

Lead Sponsor

Trials
1,594
Recruited
10,430,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

Family-focused therapy (FFT) significantly improved family functioning over 24 months in high-risk youth for bipolar disorder compared to psychoeducation-only treatment, suggesting that family dynamics play a crucial role in managing mood symptoms.
Improvements in family functioning were found to partially mediate reductions in depressive symptoms, indicating that addressing family relationships can be an effective strategy in treating early signs of bipolar disorder.
Effects of family intervention on psychosocial functioning and mood symptoms of youth at high risk for bipolar disorder.Weintraub, MJ., Schneck, CD., Posta, F., et al.[2022]
Family-focused therapy (FFT) is particularly effective in reducing positive symptoms of psychosis in individuals at high risk for conversion to psychosis, as shown in a study involving 94 participants.
Higher-risk individuals showed significantly greater improvement with FFT compared to enhanced care or standard treatment, indicating that intensive interventions may be best suited for those with the highest risk levels.
Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator.Worthington, MA., Miklowitz, DJ., O'Brien, M., et al.[2022]
A pilot randomized trial involving 47 clinicians and 34 patients with mood or psychotic disorders found that both high-intensity and low-intensity training methods for Family-Focused Therapy (FFT) resulted in similar fidelity to the treatment protocol.
Both training methods led to improvements in parent/offspring conflict, indicating that low-intensity training is a feasible option that does not compromise treatment efficacy for FFT.
Effects of High- versus Low-Intensity Clinician Training on Implementation of Family-Focused Therapy for Youth with Mood and Psychotic Disorders.Miklowitz, DJ., Weintraub, MJ., Posta, F., et al.[2022]

References

Effects of family intervention on psychosocial functioning and mood symptoms of youth at high risk for bipolar disorder. [2022]
Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator. [2022]
Effects of High- versus Low-Intensity Clinician Training on Implementation of Family-Focused Therapy for Youth with Mood and Psychotic Disorders. [2022]
A randomized trial of family focused therapy with populations at clinical high risk for psychosis: effects on interactional behavior. [2021]
Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial. [2022]
A Randomized Comparison of Two Psychosocial Interventions on Family Functioning in Adolescents with Bipolar Disorder. [2021]
Family communication and the efficacy of family focused therapy in individuals at clinical high risk for psychosis with comorbid anxiety. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security